4.6 Article

A Single Bout of High-Intensity Interval Exercise Does Not Increase Endothelial or Platelet Microparticles in Stable, Physically Fit Men With Coronary Heart Disease

Journal

CANADIAN JOURNAL OF CARDIOLOGY
Volume 29, Issue 10, Pages 1285-1291

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cjca.2013.03.024

Keywords

-

Funding

  1. EPIC Foundation

Ask authors/readers for more resources

Background: High-intensity interval exercise (HIIE) is gaining in popularity in fitness centres, even among coronary heart disease (CHD) patients. However, whether HIIE can have deleterious acute effects on the vasculature in CHD has not been studied. We hypothesized that when compared with moderate-intensity continuous exercise (MICE), a single bout of HIIE could lead to vascular damage and increasing numbers of circulating endothelial and platelet microparticles (EMPs, PMPs) in stable, physically fit CHD patients. Methods: Nineteen male CHD patients (aged 62 +/- 11 years) underwent, in random order, a single session of HIIE corresponding to 15second intervals at 100% of peak power output and 15-second passive recovery intervals, and an isocaloric MICE session. EMPs (CD31(+)and/or CD62E and CD42b(+)); PMPs (CD42b(+)); nitrates and nitrites; prostacycline; and troponin T, cardiac form (cTnT), were measured 10 minutes before exercise and 20 minutes, 24 hours, and 72 hours after both exercise sessions. Results: EMPs, PMPs, nitrates and nitrites, prostacycline, and cTnT remained unchanged after both HIIE and MICE exercise sessions. Initial EMP concentration correlated inversely with EMP concentration 20 minutes post exercise, irrespective of exercise modality (r = 0.78, P < 0.0001). Conclusions: A single HIIE session with very short exercise and passive recovery periods appears safe and does not induce changes to markers of endothelial function. Future studies are required to determine the safety of a long-term HIIE training program.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, Research & Experimental

Retrospective Study of 573 Patients with Heart Failure Evaluated for Coronary Artery Disease at Toulouse University Center, France

Antoine Deney, Vanessa Nader, Anthony Matta, Romain Itier, Pauline Fournier, Olivier Lairez, Nathalie Pizzinat, Didier Carrie, Frederic Boal, Michel Galinier, Oksana Kunduzova, Rania Azar, Jerome Roncalli

Summary: This study found that more than half of patients with heart failure had coronary artery disease, and older age and male sex were common risk factors for both HFpEF and HFrEF.

MEDICAL SCIENCE MONITOR (2022)

Article Endocrinology & Metabolism

Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

Subodh Verma, Nitish K. Dhingra, Javed Butler, Stefan D. Anker, Joao Pedro Ferreira, Gerasimos Filippatos, James L. Januzzi, Carolyn S. P. Lam, Naveed Sattar, Barbara Peil, Matias Nordaby, Martina Brueckmann, Stuart J. Pocock, Faiez Zannad, Milton Packer

Summary: This study analyzed the efficacy and safety of empagliflozin in patients with heart failure with reduced ejection fraction in addition to background foundational treatments. The results showed that empagliflozin reduced the risk of cardiovascular death and heart failure hospitalization, as well as total heart failure hospital admissions, regardless of background therapy or medication doses. Empagliflozin was well tolerated across all subgroups of patients.

LANCET DIABETES & ENDOCRINOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Adenylate cyclase type 9 antagonizes cAMP accumulation and regulates endothelial signalling involved in atheroprotection

Yohann Rautureau, Marianne Berlatie, Daniel Rivas, Kurunradeth Uy, Alexandre Blanchette, Geraldine Miquel, Marie-Eve Higgins, Melanie Mecteau, Audrey Nault, Louis Villeneuve, Veronique Lavoie, Gabriel Theberge-Julien, Genevieve Brand, Line Lapointe, Maxime Denis, Camille Rosa, Annik Fortier, Lucie Blondeau, Marie-Claude Guertin, Marie-Pierre Dube, Eric Thorin, Jonathan Ledoux, David Rhainds, Eric Rheaume, Jean-Claude Tardif

Summary: ADCY9 gene plays a role in determining atherosclerotic outcomes in patients and in mice it has been shown to potentiate endothelial function and inhibit atherogenesis. The inactivation of Adcy9 leads to increased cAMP accumulation in response to certain activators and enhances endothelial-dependent vasodilation. Additionally, ADCY9 can regulate endothelial permeability and actin cytoskeleton in response to thrombin, affecting the development of atherosclerosis.

CARDIOVASCULAR RESEARCH (2023)

Correction Cardiac & Cardiovascular Systems

Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (Mar, 10.1007/s00392-022-01996-2, 2022)

Gregory Y. H. Lip, Agnieszka Kotalczyk, Christine Teutsch, Hans-Christoph Diener, Sergio J. Dubner, Jonathan L. Halperin, Chang-Sheng Ma, Kenneth J. Rothman, Sabrina Marler, Venkatesh Kumar Gurusamy, Menno V. Huisman

Summary: The name of the GLORIA-AF investigator was mistakenly written as Athanasios Kollias instead of Anastasios Kollias in the Acknowledgements section of the article. The error has been corrected.

CLINICAL RESEARCH IN CARDIOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry

Gregory Y. H. Lip, Agnieszka Kotalczyk, Christine Teutsch, Hans-Christoph Diener, Sergio J. Dubner, Jonathan L. Halperin, Chang-Sheng Ma, Kenneth J. Rothman, Sabrina Marler, Venkatesh Kumar Gurusamy, Menno Huisman

Summary: This study compared the safety and effectiveness of different non-vitamin K antagonists (NOACs) in newly diagnosed atrial fibrillation (AF) patients. The results showed that dabigatran had a lower risk of major bleeding compared to rivaroxaban, but similar risks of stroke, myocardial infarction (MI), and death. Patients treated with dabigatran had similar risks of stroke, major bleeding, MI, and death compared to apixaban. Rivaroxaban had an increased risk of major bleeding compared to apixaban, but similar risks of stroke, MI, and death.

CLINICAL RESEARCH IN CARDIOLOGY (2022)

Article Environmental Sciences

Cardiopulmonary Rehabilitation in Long-COVID-19 Patients with Persistent Breathlessness and Fatigue: The COVID-Rehab Study

Florent Besnier, Beatrice Berube, Jacques Malo, Christine Gagnon, Catherine-Alexandra Gregoire, Martin Juneau, Francois Simard, Philippe L'Allier, Anil Nigam, Josep Iglesies-Grau, Thomas Vincent, Deborah Talamonti, Emma Gabrielle Dupuy, Hanieh Mohammadi, Mathieu Gayda, Louis Bherer

Summary: The COVID-Rehab study investigates the effectiveness of an eight-week cardiopulmonary rehabilitation program for long-term COVID-19 patients. The study examines multiple outcomes including cardiorespiratory fitness, quality of life, and cognition. The findings will provide important guidance for the rehabilitation of long-term COVID-19 patients.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Review Cell Biology

Pre-Conditioning Methods and Novel Approaches with Mesenchymal Stem Cells Therapy in Cardiovascular Disease

Anthony Matta, Vanessa Nader, Marine Lebrin, Fabian Gross, Anne-Catherine Prats, Daniel Cussac, Michel Galinier, Jerome Roncalli

Summary: Transplantation of mesenchymal stem cells (MSCs) has shown good clinical outcomes in cardiovascular diseases such as heart failure, cardiomyopathy, and ischemic heart disease. This is attributed to reduced ventricular remodeling, myocardial fibrosis, scar size, and improved endothelial dysfunction. MSCs also exhibit regenerative, pro-angiogenic, anti-apoptotic, and anti-inflammatory effects. This review focuses on different preconditioning methods and novel approaches to optimize the efficacy of MSC therapy.

CELLS (2022)

Article Cardiac & Cardiovascular Systems

Myocardial bridging is significantly associated to myocardial infarction with non-obstructive coronary arteries

Anthony Matta, Vanessa Nader, Ronan Canitrot, Clement Delmas, Frederic Bouisset, Thibault Lhermusier, Stephanie Blanco, Francisco Campelo-Parada, Meyer Elbaz, Didier Carrie, Michel Galinier, Jerome Roncalli

Summary: This study aims to investigate the relationship between myocardial bridging (MB) and myocardial infarction with non-obstructive coronary arteries (MINOCA). The results showed that MB is a risk factor for MINOCA, with MINOCA mainly presenting as non-ST-segment elevation myocardial infarction. Further investigation for MB in MINOCA cases, especially in non-ST-segment elevation myocardial infarction patients, seems necessary.

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2022)

Article Cardiac & Cardiovascular Systems

Prevalence, management, and outcomes of haemorrhagic events in left ventricular assist device recipients

Laetitia Pourtau, Maxime Beneyto, Jean Porterie, Jerome Roncalli, Montse Massot, Caroline Biendel, Pauline Fournier, Romain Itier, Michel Galinier, Olivier Lairez, Clement Delmas

Summary: This study aimed to investigate the prevalence, management, and outcomes of haemorrhagic adverse events in patients receiving left ventricular assist devices (LVADs). The study found that bleeding events were frequent and associated with increased mortality, with gastrointestinal bleeding being the most common and intracranial haemorrhage being the most associated with mortality.

ESC HEART FAILURE (2022)

Article Cardiac & Cardiovascular Systems

Healthcare costs of a telemonitoring programme for heart failure: indirect deterministic data linkage analysis

Atul Pathak, Pierre Levy, Francois Roubille, Gilles Chatellier, Gregoire Mercier, Sarah Alami, Guila Lancman, Helene Pasche, Corinne Laurelli, Cecile Delval, Juan Fernando Ramirez-Gil, Michel Galinier

Summary: This study compared the healthcare resource consumption costs for chronic heart failure patients under telemonitoring and standard of care, with a slight cost reduction in the telemonitoring group over 18 months, primarily due to a decrease in nurse fees. Patients with severe heart failure showed a non-significant reduction in costs under telemonitoring, particularly in hospitalization and nursing fees.

ESC HEART FAILURE (2022)

Article Cardiac & Cardiovascular Systems

Benefits of Interventional Telemonitoring on Survival and Unplanned Hospitalization in Patients With Chronic Heart Failure

Michel Galinier, Romain Itier, Anthony Matta, Montse Massot, Pauline Fournier, Ghislaine Galtier, Sandrine Ayot, Vanessa Nader, Max Rene, Laurent Lecourt, Jerome Roncalli

Summary: The study assessed the effects of interventional specialized telemonitoring (ITM) compared to standard telemonitoring (STM) and standard of care (SC) on preventing all causes of death, cardiovascular mortality, and unplanned hospitalization in heart failure (HF) patients. The results showed that the ITM group had lower rates of unplanned hospitalization and all causes of death compared to the SC and STM groups.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Article Biochemistry & Molecular Biology

Dalcetrapib and anacetrapib increase apolipoprotein E-containing HDL in rabbits and humans

Mathieu R. Brodeur, David Rhainds, Daniel Charpentier, Marie Boule, Teodora Mihalache-Avram, Melanie Mecteau, Genevieve Brand, Valerie Pedneault-Gagnon, Annik Fortier, Eric J. Niesor, Eric Rheaume, Cyrille Maugeais, Jean-Claude Tardif

Summary: The effects of CETP inhibitors on HDL particle composition were studied in rabbits and humans. The study found that these inhibitors increased the concentration of large apo E-containing HDL particles, which can interact with hepatic LDL receptors.

JOURNAL OF LIPID RESEARCH (2023)

Article Biochemistry & Molecular Biology

High-density lipoprotein cholesterol efflux capacity in patients with obstructive sleep apnea and its relation with disease severity

Reza Fadaei, Samaneh Mohassel Azadi, Eric Rheaume, Habibolah Khazaie

Summary: Obstructive sleep apnea (OSA) is associated with an increased risk of cardiovascular disease (CVD), and HDL cholesterol efflux capacity (CEC) may be impaired in OSA patients, potentially contributing to the risk of CVD.

LIPIDS IN HEALTH AND DISEASE (2022)

Article Materials Science, Multidisciplinary

Multifaceted ligand design facilitates chemical- or peptide-mediated linking of hollow gold nanoshells with tuned interparticle distance, interference and cytotoxicities

Yu-Chen Wang, Gabriel Theberge-Julien, Jean-Claude Tardif, Eric Rheaume, Frederic Lesage, Ashok Kakkar

Summary: We report a versatile methodology to covalently link hollow gold nanoshells (HAuNS) through the modular design of multi-tasking ligands and bio-adaptable chemistry. Ligand composition includes polyethylene glycol (PEG) chains, protected thiol-terminated tetraethylene glycol, and a reactive functional group. HAuNS are functionalized through in situ deprotection/thiol-Au binding. The ligand-functionalized HAuNS with surface exposed COOH or OH entities are used to construct linked-HAuNS through short chemical or longer bio-spacers, regulating inter-particle distance and interference of HAuNS surface plasmon resonance. The synthetic tools and facile chemistry described here provide opportunities in designing linked metal nanoparticles for broad applications in biology.

MATERIALS ADVANCES (2022)

No Data Available